drugset / Trial / NCT05778838

Midodrine Effect on the Mortality Rates in Septic Shock Patients

NCT05778838

Phase 2 Completed 100 enrolled Noha Mansour
RandomizedParallel-groupOpen-labelTreatment

Summary

Assessing the safety and efficacy of the adjunctive use of midodrine as a vasopressor in septic shock patients by measuring the difference in the mortality rates between control and intervention groups.

Timeline

Start
2022-11-07
Primary completion
2023-12-22
Completion
2024-01-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Midodrine Small molecule 10 mg Oral